Ceftobiprole for the treatment of pneumonia: a European perspective

Ceftobiprole, a new broad spectrum, parenteral cephalosporin, exhibits potent in vitro activity against a number of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae, and Gram-negative pathogens associated with hospital-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liapikou, Adamantia, Cillóniz, Catia, Torres, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547641/
https://www.ncbi.nlm.nih.gov/pubmed/26316697
http://dx.doi.org/10.2147/DDDT.S56616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547641/
https://www.ncbi.nlm.nih.gov/pubmed/26316697
http://dx.doi.org/10.2147/DDDT.S56616

Ejemplares similares